LeMaitre Vascular, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from LeMaitre Vascular, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 7.7 times. Higher than 93% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 27.6 times by its yearly operating cash. Higher than 92% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$123Over the last 3 years, every $100 of reported profit came with $123 of operating cash.
Lower than 70% of Healthcare companies in United States.
Self-Funding Ratio
7.7×Over the last 3 years its own operating cash covered its investment spending (capex) 7.7 times.
Higher than 93% of Healthcare companies in United States.
Cash Locked Ratio
$27For every $100 of sales, $27 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $33 tied up three years earlier.
More money tied up than 59% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$42Sales grew 54% in 3 years; of every extra $100 of sales, $42 became extra profit.
Higher than 65% of Healthcare companies in United States.
Asset Productivity Ratio
+54% / +98%In 3 years sales changed by +54% while total assets changed by +98%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
27.6×Debt due within a year is covered 27.6 times by its yearly operating cash.
Higher than 92% of Healthcare companies in United States.
Cash Cushion Ratio
+9%Cash, after subtracting all debt, equals 9% of its market value (net cash).
Lower than 51% of Healthcare companies in United States.
Tangible Assets Ratio
84%Of every $100 the company owns, $84 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 54% of Healthcare companies in United States.
Tangible Net Worth Ratio
75%Of every $100 of net worth, $75 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 59% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
LeMaitre Vascular, Inc. owes $0.34 for every $1 it owns. Net profit rose 31% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
29.9Investors pay $29.9 for every $1 of LeMaitre Vascular, Inc.'s yearly profit, higher than 57% of Healthcare companies in United States.
P/B ratio
4.64The share price is 4.64 times LeMaitre Vascular, Inc.'s book value per share, higher than 70% of Healthcare companies in United States.
Market cap
$2.0 BThe total market value of all of LeMaitre Vascular, Inc.'s shares at today's price (share price × number of shares), larger than 75% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$420 MWhat LeMaitre Vascular, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$18.38Net worth divided by the number of shares. The share price of $85.33 is 4.6 times this, which is the P/B above.
Return on equity (ROE)
16.8%LeMaitre Vascular, Inc. earned 16.8% on its shareholders' money over the last year, higher than 88% of Healthcare companies in United States.
Owes vs Owns
0.34×LeMaitre Vascular, Inc. owes $0.34 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.
Dividend yield
1.19%LeMaitre Vascular, Inc. pays 1.19% of its share price as dividends a year, higher than 57% of dividend-paying Healthcare companies in United States.
Revenue growth
+14%Revenue rose 14% in the year to Dec 2025, and grew 16% a year on average over 3 years.
Profit growth
+31%Net profit rose 31% in the year to Dec 2025, and grew 41% a year on average over 3 years.
Profit margin
23.1%LeMaitre Vascular, Inc. keeps $23 of every $100 of revenue as net profit.
Cash quality
1.4×Cash from LeMaitre Vascular, Inc.'s business was 1.4× its reported profit in the year to Dec 2025 — its profit turned into cash.
Interest cover
13.1×LeMaitre Vascular, Inc.'s operating profit covered its interest costs 13.1 times in the year to Dec 2025.
Cash vs debt
Net cashLeMaitre Vascular, Inc. held $174 M more cash than debt (net cash) at Dec 2025.
Questions
What is LeMaitre Vascular, Inc.'s P/E ratio?
Investors pay $29.9 for every $1 of LeMaitre Vascular, Inc.'s yearly profit, higher than 57% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For LeMaitre Vascular, Inc.: $2.0 B ÷ $420 M (30 Jun 2026) = 4.6.
What is LeMaitre Vascular, Inc.'s return on equity?
LeMaitre Vascular, Inc. earned 16.8% on its shareholders' money over the last year, higher than 88% of Healthcare companies in United States.
How much does LeMaitre Vascular, Inc. owe compared with what it owns?
LeMaitre Vascular, Inc. owes $0.34 for every $1 it owns (low), lower than 56% of Healthcare companies in United States.
Does LeMaitre Vascular, Inc. pay a dividend?
Yes. LeMaitre Vascular, Inc. pays 1.19% of its share price as dividends a year, higher than 57% of dividend-paying Healthcare companies in United States.
Is LeMaitre Vascular, Inc.'s revenue growing?
Revenue rose 14% in the year to Dec 2025, and grew 16% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.